MoneyWorks4Me

The Revenue for the quarter ended  March 2025 of Rs. 11574.00 millions grew by 19.96 % from Rs. 9648.00 millions.Net profit stood at Rs. 4281.00  millions  compared to Rs. 3491.00 millions in the corresponding previous quarter,high by 22.63%.Operating profit surged to 6233.00 millions from the corresponding previous quarter of 4886.00 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 11574.00 9648.00 19.96 40945.00 35689.00 14.73 40945.00 35689.00 14.73
Other Income 621.00 359.00 72.98 3213.00 1047.00 206.88 3213.00 1047.00 206.88
PBIDT 6233.00 4886.00 27.57 24656.00 17417.00 41.56 24656.00 17417.00 41.56
Interest 88.00 45.00 95.56 196.00 145.00 35.17 196.00 145.00 35.17
PBDT 6145.00 4841.00 26.94 24460.00 17272.00 41.62 24460.00 17272.00 41.62
Depreciation 937.00 516.00 81.59 2200.00 1719.00 27.98 2200.00 1719.00 27.98
PBT 5208.00 4325.00 20.42 22260.00 15553.00 43.12 22260.00 15553.00 43.12
TAX 927.00 834.00 11.15 3756.00 2487.00 51.03 3756.00 2487.00 51.03
Deferred Tax -67.00 -2.00 3250.00 -319.00 -361.00 -11.63 -319.00 -361.00 -11.63
PAT 4281.00 3491.00 22.63 18504.00 13066.00 41.62 18504.00 13066.00 41.62
Equity 358.00 358.00 0.00 358.00 358.00 0.00 358.00 358.00 0.00
PBIDTM(%) 53.85 50.64 6.34 60.22 48.80 23.39 60.22 48.80 23.39
Peers
Company Name CMP
Sun Pharma. Inds. 1842.00
Dr. Reddys Labs. 1161.00
Cipla 1365.00
Lupin 2096.00
Zydus Lifesciences 1119.50
View more..